UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in PCVX — Vaxcyte, Inc.
CIK 861177
NEW YORK, NY
Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,598,196
-$2,262,057 QoQ
Shares Held
371,550
-9.5% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 329 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. PCVX ranks #29 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in PCVX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,598,196 | 371,550 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $23,860,253 | 410,605 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $17,948,917 | 389,010 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,341,143 | 398,144 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,043,304 | 555,008 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,408,560 | 513,998 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $38,716,828 | 472,964 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $46,653,465 | 408,274 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,332,982 | 295,762 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,378,298 | 108,012 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,116,503 | 81,473 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,797,906 | 74,498 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,798,186 | 56,031 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,100,040 | 56,031 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,478,101 | 51,681 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $831,072 | 34,628 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $224,824 | 10,332 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||